Osaic Holdings’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,000
| Closed | -$1.44K | – | 7944 |
|
|
2025
Q3 | $1.44K | Hold |
6,000
| – | – | ﹤0.01% | 7235 |
|
|
2025
Q2 | $10.2K | Hold |
6,000
| – | – | ﹤0.01% | 6131 |
|
|
2025
Q1 | $9.48K | Hold |
6,000
| – | – | ﹤0.01% | 5812 |
|
|
2024
Q4 | $10.7K | Hold |
6,000
| – | – | ﹤0.01% | 5760 |
|
|
2024
Q3 | $36.4K | Hold |
6,000
| – | – | ﹤0.01% | 4963 |
|
|
2024
Q2 | $31.6K | Hold |
6,000
| – | – | ﹤0.01% | 5028 |
|
|
2024
Q1 | $50.9K | Hold |
6,000
| – | – | ﹤0.01% | 4744 |
|
|
2023
Q4 | $39.6K | Sell |
6,000
-6,000
| -50% | -$29.6K | ﹤0.01% | 5056 |
|
|
2023
Q3 | $37.1K | Buy |
12,000
+6,775
| +130% | +$19.5K | ﹤0.01% | 5191 |
|
|
2023
Q2 | $14.1K | Hold |
5,225
| – | – | ﹤0.01% | 5774 |
|
|
2023
Q1 | $15.5K | Hold |
5,225
| – | – | ﹤0.01% | 5712 |
|
|
2022
Q4 | $13K | Buy |
5,225
+1,000
| +24% | +$2.87K | ﹤0.01% | 5804 |
|
|
2022
Q3 | $8K | Hold |
4,225
| – | – | ﹤0.01% | 6115 |
|
|
2022
Q2 | $13K | Hold |
4,225
| – | – | ﹤0.01% | 5890 |
|
|
2022
Q1 | $26K | Sell |
4,225
-334
| -7% | -$2.94K | ﹤0.01% | 5518 |
|
|
2021
Q4 | $65K | Sell |
4,559
-1,842
| -29% | -$20.5K | ﹤0.01% | 4935 |
|
|
2021
Q3 | $51K | Sell |
6,401
-16,764
| -72% | -$267K | ﹤0.01% | 5080 |
|
|
2021
Q2 | $662K | Buy |
23,165
+1,220
| +6% | +$35.5K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $638K | Buy |
21,945
+7,945
| +57% | +$185K | ﹤0.01% | 2629 |
|
|
2020
Q4 | $167K | Buy |
14,000
+4,500
| +47% | +$31.7K | ﹤0.01% | 3633 |
|
|
2020
Q3 | $66K | Hold |
9,500
| – | – | ﹤0.01% | 4114 |
|
|
2020
Q2 | $59K | Buy |
9,500
+1,000
| +12% | +$4.74K | ﹤0.01% | 4070 |
|
|
2020
Q1 | $34K | Buy |
+8,500
| New | +$42.8K | ﹤0.01% | 4266 |
|
Osaic Holdings's EPIX Position: Q4 2025 in Review
Osaic Holdings sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 6,000 shares — an estimated $1.44K sold.
Osaic Holdings first reported a position in EPIX in Q1 2020 and held it in 23 quarters. The position peaked at $662K in Q2 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Osaic Holdings reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 6,000 ESSA Pharma shares in Q4 2025, an estimated $1.44K.
- Osaic Holdings first reported a position in ESSA Pharma in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's ESSA Pharma position peaked at $662K in Q2 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.